posted
ya i just posted this to iam in this one at .21 the bid is stacking and it looks like it didnt have any sells today this is the bounce on this stock its looking good gl people
Posts: 36 | Registered: Sep 2005
| IP: Logged |
<ryandsgfer>
unregistered
posted
why cant i buy from scotttrader
IP: Logged |
posted
efsf getting buys premarket the mm are stacking the bid it looks like it hit its bottom at .20 and its going to start moving back up good luck
Posts: 36 | Registered: Sep 2005
| IP: Logged |
posted
i hit bottom already and all buys today i dont see what you dont like do you have L2? it looks great
Posts: 1423 | Registered: Jul 2005
| IP: Logged |
posted
I'm looking at the chart that shows a bottom of.16 back in august. just looks as if its headed that way. not to say that it couldnt change directions. might of stabilized here. ive read some of your picks,rider,and you are usually right on, so this is only my take on this stock.
-------------------- jordan Posts: 5812 | From: st paul,mn | Registered: Feb 2004
| IP: Logged |
posted
I've been holding this stock for a long time.I am currently taking a large loss, but this stock should move well in Feb. when they have announced the EPA approval for the big 6+ germicidal they have been awaiting for over a year.Maybe sooner if it gets another push from konlin letter which it seems to recieve about every 6 months.I've had high hopes for this one.Could play big next year.
Posts: 23 | From: Kentucky | Registered: Nov 2005
| IP: Logged |
posted
Hi all, I'm new to pennies but have been following some posts lately. I bought a small lot of this to diversify my penny-portfolio, though I'm not sure it qualifies as a portfolio yet, lol.
Etrade shows last price of .65 in extended hours - is this a fluke after a close at .205? Seems like a big difference there.
Help a n00b out? I don't understand why this would show .65 cents.
-------------------- ~-------------~ Don't sweat me. Posts: 52 | From: Delaware, USA | Registered: Dec 2005
| IP: Logged |
posted
Patricia Ross-Gruden, President and CEO of eFoodSafety.com, Inc. (OTCBB: EFSF) announced today that The KonLin Letter provided an update on EFSF.OB to its subscribers in its December 2005 issue.
The KonLin Letter (TKL) stated that in less than one quarter, the Company has reorganized itself into a "dynamo" unlike any other low-priced stock followed in TKL's history.
Mr. Konrad Kuhn, editor, emphasized that he believes in both the company and its management and that all of the company's products are entering into multi-billion dollar markets.
The Company is pleased to report the status of its current product offerings:
-- Talsyn(TM)-CI/bid Scar Cream has entered the $4 bil. Scar cream market and the product is currently being sold.
-- Cinnergen(TM), a non-prescription diabetes product has entered the $132 bil. diabetes market and this product is currently being sold also.
-- Trimmendous(TM), an all-natural weight loss formula is scheduled to enter the $33 bil. domestic market of obesity in January 2006.
-- Citroxin Cleaner has been sold in Louisiana to aid in the restoration of hurricane-damaged areas and eradicate Black Mold.
-- Most important, the Big Six Plus Germicidal is able to eradicate the Bird Flu, which has killed over 150 mil. birds and was fatal to over half of the people infected. EFSF can prevent and treat this potential pandemic NOW.
"The shareholders should understand that The KonLin Letter is an unpaid research firm and Mr. Kuhn has spent many hours reviewing our products, business model, and strategies, and has had numerous discussions with management prior to formulating his opinions. We are glad to see that The KonLin Letter has taken the time to understand what monumental strides we have made since I assumed the role as President and CEO," stated Patricia Ross-Gruden.
About Kon-Lin Research & Analysis Corp.
The KonLin Letter, www.KonLin.com, chooses low-priced stocks to analyze, with an emphasis on emerging growth and special situations poised for explosive price appreciation. The KonLin Letter has constantly been one of the leading publications on Wall Street. It has been rated one of the best performing market letters in the nation, offering a unique service that each month recommends five low-priced selections, including a featured stock of the month.
About eFoodSafety.com, Inc.
eFoodSafety.com, Inc. is dedicated to improving food and health conditions around the world through its innovative technologies. The company's Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The company's MedElite, Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It is the exclusive U.S. and worldwide distributor of the Talsyn(TM)-CI/bid Scar Cream that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com). The company is also is a distributor for Cinnergen(TM), a non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism (www.cinnergen.com), and most recently became a distributor for Trimmendous, a weight loss formula emphasizing on the body's 24-hour metabolic processes.
Safe Harbor Forward-Looking Statements
Statements contained in this release that are not strictly historical are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements are made based on information available as of the date hereof, and the company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements invoke risk and uncertainties and the company's actual results may differ from these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the company and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.
posted
eFoodSafety.com Inc. Subsidiary, Knock-Out Technologies Ltd., Receives EPA Registration on Its Big 6 Plus Germicidal Product via COMTEX
February 2, 2006
SCOTTSDALE, Ariz., Feb 02, 2006 (BUSINESS WIRE) --
Robert Bowker, president/CEO of Knock-Out Technologies Ltd., a wholly owned subsidiary of eFoodSafety.com Inc. (OTCBB: EFSF), announced today that the Environmental Protection Agency (EPA) has issued Registration No. 82723-1 for the company's Big 6 Plus Germicidal product.
Laboratory testing of the Big 6 Plus Germicidal has proved it eradicates E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus. Recently, there has been laboratory documentation that proved it also killed a strain of Avian Influenza, Candida Albicans, the most common fungal infection in immunosuppressed patients, as well as Stachybotrys Chartarum mold spores (Black Mold).
"The functionality of this completely safe, broad-spectrum germicidal product allows us to pursue various health-related issues and markets, such as industrial areas, schools, veterinary facilities, hospitals, nursing homes, health facilities, and restaurants," stated Bowker.
During the review of our application, the EPA assessed the hazards that may be posed by the Big 6 Plus Germicidal to human health and the environment, as well as examined the ingredients, the site on which it is to be used, the amount, the frequency and timing of its use, and storage and disposal practices. The EPA's evaluation concluded that the Big 6 Plus will not have adverse effects on humans, the environment and non-target species.
"Through the extensive approval process by the EPA and its subsequent issuing of the registration number, we now have the recognized credibility to market the Big 6 Plus Germicidal product. We feel our company continues to document and seek the necessary credentials for all of our products to assure our customers and our shareholders that eFoodSafety.com will only produce and market proven technology," stated Patricia Ross-Gruden, president and CEO of eFoodSafety.com Inc.
About eFoodSafety.com Inc.
eFoodSafety.com Inc. is dedicated to improving food and health conditions around the world through its innovative technologies. The company's Knock-Out Technologies Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax, and a germicidal product, Big 6 Plus -- EPA Reg. No. 82723-1, that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus and Streptococcus; and Avian Influenza and Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The company's MedElite Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It is the exclusive U.S. and worldwide distributor of the Talsyn(TM)-CI/bid Scar Cream that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com). The company is also a distributor for Cinnergen(TM), a non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism (www.cinnergen.com), and most recently became a distributor for Trimmendous(TM), a weight loss formula focusing on the body's 24-hour metabolic processes.
Safe Harbor Forward-Looking Statements
Statements contained in this release that are not strictly historical are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements are made based on information available as of the date hereof, and the company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements invoke risk and uncertainties and the company's actual results may differ from these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the company and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Smile]](smile.gif)
